Medical Condition News

RSS

Renowned physicians encourage women to go for regular breast examinations

Doctors Ritu Chopra and Andrew Ordon, respected physicians with practices in Rancho Mirage and Beverly Hills, are encouraging Coachella Valley women to obtain regular breast exams and to be aware of their general breast health.

13 Oct 2009

Amsterdam Molecular Therapeutics' AMT-080 granted EMEA Orphan Drug Designation

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.

13 Oct 2009

NIH funds the University of California's consortium for immune disorder research

The University of California, San Francisco has been designated to lead a new consortium that will study a group of severe immune disorders known as primary immunodeficiencies and aims to improve treatment for these often life-threatening diseases. The Primary Immune Deficiency Treatment Consortium comprises 13 centers throughout the United States and has a $6.25 million funding commitment over five years from the National Institutes of Health.

13 Oct 2009

Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl

Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group, announced that the 6-month sustained-release formulation of Decapeptyl®1 (triptorelin embonate2 22.5 mg) successfully completed its European decentralised registration procedure involving nine countries: Germany (reference member state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands.

13 Oct 2009

Kidney Care Partners commends CBC for supporting reforms to improve access to quality kidney care

Kidney Care Partners - an alliance of patient advocates, dialysis professionals, care providers and manufacturers working together to improve quality of care for individuals with kidney disease and kidney failure - today applauded the Congressional Black Caucus (CBC) for supporting reforms that will improve patient access and choice in receiving quality kidney care.

13 Oct 2009

VitalProteinRx nutritional supplement for chronic kidney disease affected patients

VitalRemedyMD, a physician-established company, offers scientifically formulated integrative nutritional supplements designed to improve the quality of traditional healthcare. "We are proud that VitalProteinRx is now an integral part of Fresenius' armamentarium in helping patients with chronic kidney disease," stated Dr. Seth Baum, Founder of VitalRemedyMD.

13 Oct 2009

Increasing number of pre-term infants experience eye disorders

As more extremely pre-term infants survive in Sweden, an increasing number of babies are experiencing vision problems caused by abnormalities involving the retina, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

13 Oct 2009

Neighborhood may be a modifiable risk factor for diabetes

Individuals living in neighborhoods conducive to physical activity and providing access to healthy foods may have a lower risk of developing type 2 diabetes in a five-year period, according to a report in the October 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

13 Oct 2009

Strengthen key muscles in the foot to improve overall performance

With summer weather finally gone, more Canadians will spend hours at the gym sculpting their muscles, but most will neglect one of the most important ones - the foot. Recent studies show neglecting the feet leads to chronic foot, knee, back, and joint pain. By strengthening key muscles in the foot, a person can improve their overall performance, energy and pain.

13 Oct 2009

Spectrum Pharmaceuticals receives Complete Response letter from the FDA for FUSILEV

Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for injection for treatment of patients with advanced metastatic colorectal cancer.

13 Oct 2009

Vanda Pharmaceuticals' Fanapt to be commercialized in the U.S. and Canada by Novartis Pharma

Titan Pharmaceuticals, Inc today announced that Vanda Pharmaceuticals, Inc. reported its entry into an exclusive agreement with Novartis Pharma AG to commercialize and develop Fanapt™ (iloperidone) in the U.S. and Canada. Fanapt™, an atypical anti-psychotic, was approved by the U.S. Food and Drug Administration earlier this summer for the acute treatment of schizophrenia in adults.

13 Oct 2009

New guidelines for treating amyotropic lateral sclerosis

Dr. John England, Professor and Chairman of Neurology at LSU Health Sciences Center New Orleans, analyzed research findings and was responsible for the quality and accuracy of evidence analysis and the conclusions of the studies resulting in new guidelines for treating Lou Gehrig's disease, or amyotropic lateral sclerosis (ALS).

13 Oct 2009

Melanocyte-like cells in heart and pulmonary veins contribute to atrial fibrillation

The source and mechanisms underlying the abnormal heart beats that initiate atrial fibrillation (Afib), the most common type of abnormal heart beat, have not been well determined. However, a group of researchers at the University of Pennsylvania, Philadelphia, has now identified a population of cells that are like pigment producing cells in the skin (melanocytes) in the atria of the heart and pulmonary veins of mice and humans and uncovered evidence in mice that these cells contribute to Afib.

13 Oct 2009

Inflammation markers not involved with the chemopreventative effect of aspirin on colorectal adenomas

Unexpectedly, inflammation markers do not appear to be involved with the chemopreventative effect of aspirin on colorectal adenomas, according to a brief communication published online October 12 in the Journal of the National Cancer Institute.

13 Oct 2009

FirstCare Texas to provide Vermedx Diabetes Information System to health care providers and patients

FirstCare Texas has signed a contract with Vermedx, Inc. to provide its patent-pending Vermedx Diabetes Information System (VDIS) for the use of health care providers and patients belonging to First Care Health Plan's health maintenance organization operating in Lubbock, Waco, Abilene, and Amarillo, Texas.

13 Oct 2009

Report shows that visual impairments are associated with the risk of death in older adults

Visual problems that cannot be corrected are associated with increased risk of death among individuals between the ages of 49 and 74, and all visual impairments may be associated with the risk of death in older adults, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

13 Oct 2009

Brookstone launches anti-snore pillow

Enjoy a peaceful night's sleep and significantly decrease the rhythmic, strident sound of your partner's incessant snoring with the Brookstone Anti-Snore Memory Foam Pillow. The specialty retailer and product development company recently launched its anti-snore pillow with a clinically tested design helpful in reducing snoring and providing comfort without altering your natural sleep style or position.

13 Oct 2009

Legendary coach helps raise awareness on osteoarthritis

After leading the U.S. men’s basketball team to Olympic gold last year and two weeks before the start of his 30th season as head coach of Duke University’s men’s basketball team, Mike Krzyzewski (Coach K), 61, is teaming up with the Arthritis Foundation to help raise awareness of the disease that nearly ended his coaching career 10 years ago.

13 Oct 2009

Public lecture at UC Riverside to focus on the evolutionary struggle for cancer

Cancer is a leading cause of death worldwide. Our evolutionary struggle with this disease is the focus of a free, public lecture at UC Riverside.

13 Oct 2009

Cognitive abilites other than memory may decline prior to clinical diagnosis in patients with Alzheimer's disease

Cognitive abilities other than memory, including visuospatial skills needed to perceive relationships between objects, may decline years prior to a clinical diagnosis in patients with Alzheimer's disease, according to a report in the October issue of Archives of Neurology, one of the JAMA/Archives journals.

13 Oct 2009

Medical Condition News

Renowned physicians encourage women to go for regular breast examinations

Amsterdam Molecular Therapeutics' AMT-080 granted EMEA Orphan Drug Designation

NIH funds the University of California's consortium for immune disorder research

Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl

Kidney Care Partners commends CBC for supporting reforms to improve access to quality kidney care

VitalProteinRx nutritional supplement for chronic kidney disease affected patients

Increasing number of pre-term infants experience eye disorders

Neighborhood may be a modifiable risk factor for diabetes

Strengthen key muscles in the foot to improve overall performance

Spectrum Pharmaceuticals receives Complete Response letter from the FDA for FUSILEV

Vanda Pharmaceuticals' Fanapt to be commercialized in the U.S. and Canada by Novartis Pharma

New guidelines for treating amyotropic lateral sclerosis

Melanocyte-like cells in heart and pulmonary veins contribute to atrial fibrillation

Inflammation markers not involved with the chemopreventative effect of aspirin on colorectal adenomas

FirstCare Texas to provide Vermedx Diabetes Information System to health care providers and patients

Report shows that visual impairments are associated with the risk of death in older adults

Brookstone launches anti-snore pillow

Legendary coach helps raise awareness on osteoarthritis

Public lecture at UC Riverside to focus on the evolutionary struggle for cancer

Cognitive abilites other than memory may decline prior to clinical diagnosis in patients with Alzheimer's disease

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News